The eosinophilic esophagitis (EoE) disease treatment market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Eosinophilic esophagitis (EOE) is a chronic allergic or immune condition where a person suffering with EOE tends to have inflammation of the esophagus. Esophagus is also known as food pipe which carries food from the mouth to the stomach. In the diseased state, a large number of white blood cells (WBCs) called eosinophils found in the food pipe. The symptoms vary with age, for toddlers, either they refuse to eat or do not grow properly; in case of school going children, they have recurring abdominal pain and also complain of trouble in swallowing or vomiting. Teenagers and adults have difficulty in swallowing dry or dense solid foods. There can be a condition where the food pipe can become too narrow to a point that food gets stuck known as food impaction and this calls for a medical emergency. Growing incidence of EoE, growing healthcare/disease awareness and growing allergy diagnostics market are some of major drivers driving the growth of the global eosinophilic esophagitis disease treatment market. In addition, technological advancements and healthcare reforms will further drive the market growth in the coming years and beyond.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the eosinophilic esophagitis disease treatment value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the eosinophilic esophagitis disease treatment market.
Major industry players profiled as part of the report are Nutricia North America, Cigna, Regeneron Pharmaceuticals, Inc., Celgene Corporation and Adare Pharmaceuticals, Inc. among others.
The eosinophilic esophagitis disease treatment market has been analyzed through following segments:
Prick Skin Testing
Blood Test (Serum Specific Immune Assay)
Food Patch Test
Food Testing Directed Diets
Empiric Elimination Diets
Middle East and Africa
Key insights offered
What will be the eosinophilic esophagitis disease treatment market size from 2017 to 2023?
How are the major drivers and restraints affecting the eosinophilic esophagitis disease treatment market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.